Pharmaceutical
CMC Technical Writing: Strengthening Change Control and Lifecycle Management
16 Dec, 2025
certified: 14001:2015, 45001:2018, 9001:2015, 27001:2022
NMSDC Certified-MBE 2022
WBE Certified
8+ CSAT score from 97% of customers






Celegence Offices
Partner Offices
Celegence HQ
Chicago, IL
Global Oversight Project & Account Management SME Consulting
Partner office
Brazil
Onshore SME Consulting
Celegence Office
London
Account Management SME Consulting
Celegence Office
Office Near Amsterdam
Regulatory Affairs Experts & Delivery Center
Celegence Office
Cluj
Software Development & Global Delivery
Celegence Office
Bangalore
Global Delivery Center of Excellence
Partner office
Onshore SME Consulting
Partner office
Tokyo
SME Consulting Center of Excellence
Technical Writing
Medical Writing
RIMS Management
Data Governance & Regulatory Compliance
Regulatory Affairs Consulting
Regulatory Intelligence
Lack of specialized in-house resources
Challenge
Our SMEs provide value that cannot be achieved internally without huge investment in resources.
Our Approach
Complexity of global standards
and requirements
Challenge
Our technology enables us to adhere to complex region-specific requirement and maintain quality consistency.
Our Approach
Tight deadlines
Challenge
Where other providers struggle, we’re able to meet the toughest deadline. Our in-house AI, automtion and template solutions relieve delivery teams from repetitive, time-consuming tasks.
Our Approach
Quality control
Challenge
Data is formatted, maintained, and secured thought out tech solutions, minimizing human error and improving data quality.
Our Approach
Small Molecules
Biologics
Generics
Advanced Therapies
Biosimilars
Combination Products
CAPTIS® AI and Automation Technology
In-house AI-powered regulatory compliance technology, designed to streamline medical writing and documentation processes. CAPTIS® AI platform reduces manual effort, enhances regulatory accuracy, and creates effortless experiences for Celegence project teams and our customers.
eCTD viewer and dossier management
Our proprietary cloud-based dossier management solution eliminates manual steps in the exchange of regulatory dossiers. It allows you to share, view, and review eCTD, NeeS, and other dossier formats from any region and access them in any location with highest level of data protection.
eCTD-Ready Templates
Intuitive MS Word templates for eCTD-ready documents without software installation include stand-alone regulatory documents for, amongst others, NDA/BLA, IND, NDS, MAA, CTA, PIP, scientific advice, and briefing packages.
Celegence in-house technology for pharmaceutical support
50%
Faster delivery with intact quality
>95%
Improved accuracy over manual processes
30%
In saving against current operational cost
Based in the Netherlands, Maurice has over 27 years’ experience in the pharmaceutical and biotech industry, mainly supporting pre-approval drugs and biologics for oncology, pulmonary and cardiovascular indications, with extensive experience in developing regulatory strategies, leading cross-functional teams in health authority interactions (Scientific Advice, both on national and EU level) regulatory intelligence and applications including document development to support applications such as MAAs, CTAs, EU & US Orphan Drug Applications, PIPs, iPSPs, IND Annual Reports and DSURs. He holds a Master’s degree in Medical Biology from the University of Utrecht and a Doctorate in Medicines from the University of Leiden, Netherlands. Fastest EU MAA approval for a monoclonal antibody in an ultra-orphan (at the time). Successfully guided a client through the PIP application process in 9 months (average is 18).
He holds a Master’s degree in Medical Biology from the University of Utrecht and a Doctorate in Medicines from the University of Leiden, Netherlands.
Fastest EU MAA approval for a monoclonal antibody in an ultra-orphan (at the time). Successfully guided a client through the PIP application process in 9 months (average is 18).
Read More
Read Less
With 20+ years of Pharmaceutical industry experience across Drug Discovery, Regulatory Affairs, and Compliance, Pradeep is a system and business process owner leading our Pharma division delivery teams. Pradeep holds a Master's degree in Biotechnology from Bangalore University.
Read More
Read Less
Maikel Bouman is our Associate Director of Regulatory Operations and Publishing, with 8 years of industry experience.
He has broad subject matter expertise on the quality control of data, document publishing, planning/coordination, management, preparation/creation, and dispatch of different types of electronic submission formats to various regulatory authorities across the Americas, Europe and Australia.
Read More
Read Less
As a manager within Regulatory Data Management at Celegence, John has extensive experience in xEVMPD, IDMP, RIMS, and Regulatory Affairs.
John has supported numerous pharmaceutical companies in their digital transformations by selecting the right regulatory information management system, extracting & remediating regulatory data, reviewing and updating underlying processes, and fostering a culture of collaboration and innovation among teams to drive successful change.
Read More
Read Less
Pharmaceutical
16 Dec, 2025
Pharmaceutical
02 Dec, 2025
Pharmaceutical
11 Nov, 2025
Pharmaceutical
04 Nov, 2025
Pharmaceutical
21 Oct, 2025
Pharmaceutical
14 Oct, 2025
Pharmaceutical
08 Oct, 2025
Pharmaceutical
24 Sep, 2025
Pharmaceutical
24 Dec, 2025
Pharmaceutical
18 Dec, 2025
Pharmaceutical
18 Nov, 2025
Pharmaceutical
13 Nov, 2025
Pharmaceutical
05 Nov, 2025
Pharmaceutical
23 Oct, 2025
Pharmaceutical
25 Sep, 2025
Pharmaceutical
11 Sep, 2025
Lean Authoring: Eliminating Redundancies And Complexities For The Pharmaceutical Industry And Health Authorities
Download our exclusive report to streamline regulatory approvals and optimize your EU scientific advice strategy.
Get instant access to the survey report that regulatory professionals are talking about: the 2024 RAPS & Celegence Regulatory & Readiness Survey.
Austrian Agency for Health and Food Safety (AGES)
Federal Agency for Medicines and Health Products (FAGG)
Bulgarian Drug Agency (BDA)
Agency for medicinal products and medical devices of Croatia (HALMED)
Ministry of Health – Pharmaceutical Services
State Institute for Drug Control (SUKL)
Danish Medicines Agency (DKMA)
State Agency of Medicines (Ravimiamet)
February 13, 2023 | North Bethesda, USA
September 28, 2023 | Berlin, Germany
April 10, 2024 | Baltimore, Maryland
October 22, 2024 | Brussels
February 3, 2025 | North Bethesda, MD
September 19, 2024 | Berlin, Germany
October 23, 2023 | Brussels , Belgium
June 20, 2022 | , Chicago, IL
EU MDR Consulting
EU IVDR Consulting
Post-Market Surveillance Services (PMS)
Post-Market Clinical Follow-up (PMCF)
US FDA Medical Device Consulting
Medical Device Technical File (DTF) / Device Master Record (DMR) Remediation
Complaints Management
MDR/IVDR gap analysis – SME Consulting
Consulting: EU-UDI, EUDAMED, PMS etc.
Regulatory Intelligence Consulting
ISO 13485 QMS implementation / remediation
Technical file creation/remediation
Medical Writing: CER, CEP, PEP, PER, PMPF, PMCF plans
Medical Writing: PMSR, PSUR, SSCP, FSCA etc.
CE Certification for MDR/IVDR
Drug-Device Combination NBoP
EU MDD & MDR, IVDD & IVDR
FDA 510(k)
Australian Guidelines (ARGMD)
China Medical Device Guidelines (NMPA)
ICH-GCP Guidelines
GPP, GLP, Guidelines
Health Canada Medical Device Regulations
Medical Device Registration
ICJME Guidelines
Ophthalmology
Respiratory
Cosmetic Surgery
Cardiovascular
Neurovascular
Diagnostic Imaging
Interventional Radiology
Orthopedics
Dental Specialties
Oncology
Female Reproductive Health
Renal Dialysis & Nephrology
Urology
Gastroenterology
Hematology
Notified Body document approvals for 300+ unique products/families
Excellent feedback from existing customers on deliverables
Referential customers
CAPTIS® AI Platform for EU MDR and IVDR Compliance
CAPTIS® is a secure, user-friendly web-based application that assists medical writers with the laborious process of creating regulatory documentation for EU MDR / IVDR compliance such as CEP/CER, PEP/PER, SVR, PMCF Plan/Report, SSCPs and more. CAPTIS® has been developed in collaboration with our experienced and qualified team of medical writers to address the real time challenges in medical writing and EU MDR / IVDR compliance.
Learn More About CAPTIS®17%
Doctorates
10%
Clinical Experts
63%
LS Graduates
10%
Engineers
Ramesh has significant experience in Medical Device and Invitro Diagnostic Devices, with more than 22 years’ experience in the Life Science Industry – specifically in NPD, PMS, QMS, and Regulatory Affairs.
Read More
Read Less
Joseph has 20 years of experience in medical device life cycle management and quality management systems (certified to ISO 13485, ISO 9001 & ISO/IEC17025). Key experience includes preparation and maintenance of technical files, product safety and vigilance reporting, clinical evaluations, risk assessment, regulatory audits, CE and notified body opinion submissions. Joseph has worked on diabetes management devices, nicotine replacement therapy (NRT) devices and pressurised metered dose inhalers (pMDI); Joseph has worked for small, medium and large Biotech companies such as Roche, OBG Pharmaceuticals and Kind Consumer Ltd.
Read More
Read Less
Medical Devices
08 Jan, 2026
Medical Devices
23 Dec, 2025
Medical Devices
08 Dec, 2025
Medical Devices
20 Nov, 2025
Medical Devices
11 Nov, 2025
Medical Devices
03 Oct, 2025
Medical Devices
26 Aug, 2025
Medical Devices
19 Aug, 2025
Medical Devices
13 Aug, 2025
Medical Devices
09 Jun, 2025
Medical Devices
26 May, 2025
Medical Devices
20 May, 2025
Medical Devices
15 Apr, 2025
Medical Devices
05 Dec, 2025
Medical Devices
08 Oct, 2025
Medical Devices
03 Oct, 2025
Medical Devices
25 Aug, 2025
Transforming Regulatory Processes Through Artificial Intelligence Pharmaceutical companies are under increasing pressure to produce structured, high-quality Chemistry, Manufacturing, and Controls (CMC) documentation often under tight timelines. Manual authoring of CMC/Module 3 content remains a bottleneck due to the sheer volume, complexity, and regulatory scrutiny involved. Celegence’s latest whitepaper explores how Generative AI is reshaping regulatory […]
Make Sure You’re EU MDR Compliant As regulatory specialists, we are aware of the burden you are probably under in making your medical device business compliant with the upcoming EU MDR which comes into force later this year. As part of our commitment to helping businesses make the transition, we have compiled a checklist which […]
Make Sure You’re EU IVDR Compliant As regulatory specialists, we are aware of the burden you are probably experiencing in making your In Vitro Diagnostic device compliant with the EU IVDR which comes into force next year. The EU IVDR affects all IVD medical devices and will bring about several major changes. As part of […]
Be the first to explore pivotal findings that will shape the future of MedTech regulation. Our survey covered key topics such as current challenges, resource allocation, advanced technologies, and regulatory processes to provide a clear picture of where the industry is headed.
Austrian Agency for Health and Food Safety (AGES)
Federal Agency for Medicines and Health Products (FAGG)
Bulgarian Drug Agency (BDA)
Agency for medicinal products and medical devices of Croatia (HALMED)
Ministry of Health – Pharmaceutical Services
State Institute for Drug Control (SUKL)
Danish Medicines Agency (DKMA)
State Agency of Medicines (Ravimiamet)
Finnish Medicines Agency (FIMEA)
National Agency for the Safety of Medicine and Health Products (ANSM)